Nephrocare Health Services Ltd

NSE: NEPHROPLUS · BSE: 544647 · Healthcare · 44 announcements

Share price: ₹643.00
Market cap: ₹6,452 Cr
Revenue (annual): ₹998.8 Cr
Net profit (annual): ₹76.84 Cr
P/E (TTM): 75.8×Sector 53.1×
Promoter holding: 63.85%+0.00% QoQ
FII holding: 8.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 11 Acquisition 6 Earnings Call 4 Financial Results 3 Employee Stock Options 3 Board Meeting Date 3 Results Update 2 Other Announcement 2 Management Change 2 Debt & Borrowing 2 Annual General Meeting 2 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Jul 2026 17:50 IST BSE

Debt & Borrowing

Nephrocare Health Services Debt & Borrowing: ₹31.22 Cr

Nephrocare provided a USD 3.3M SBLC for its Singapore subsidiary. This creates a contingent liability of INR 31.22 Crore for investors to note.

Value: ₹31.22 Cr

Read the filing ↗

25 Jun 2026 16:57 IST NSE

Debt & Borrowing

Nephrocare Health Services Debt & Borrowing: ₹83.86 Cr

Nephrocare Health Services provided guarantees totaling ₹83.72 Crore. These support credit facilities for its subsidiaries in Philippines and Singapore.

Value: ₹83.86 Cr

Read the filing ↗